Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pulse BiosciencesPLSE -2.16%33 3-Year EPS without NRI Growth Rate is 13.90% as of Jun. 2026, which is 271% above its 10-year median of 3.75. GuruFocus rates PLSE with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 658 Medical Devices & Instruments companies, Pulse Biosciences ranks better than 58.05% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 13.90% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 17.40% per year.
During the past 10 years, the average EPS without NRI Growth Rate was -3.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Pulse Biosciences was 26.10% per year. The lowest was -81.00% per year. And the median was 3.75% per year.
Pulse Biosciences (NAS:PLSE) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Pulse Biosciences 3-Year EPS without NRI Growth Rate Related Terms
PLSE vs LMAT, ATRC, XRAY: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Pulse Biosciences's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulse Biosciences 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulse Biosciences's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Pulse Biosciences's 3-Year EPS without NRI Growth Rate falls into.
Pulse Biosciences 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 13.90% mean?
Pulse Biosciences (PLSE) has a 3-Year EPS without NRI Growth Rate of 13.90% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Pulse Biosciences and its competitors. This is 271% above median its historical median of 3.75. According to the industry distribution chart, Pulse Biosciences ranks #276 out of 658 companies in the Medical Devices & Instruments industry, placing it in the top 41.9%.
Is Pulse Biosciences' 3-Year EPS without NRI Growth Rate too high?
Pulse Biosciences' current 3-Year EPS without NRI Growth Rate of 13.90% is 271% above median its 10-year median of 3.75. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 8.05. Pulse Biosciences' value of 13.90% is 72.7% above this industry median. Based on the distribution chart, Pulse Biosciences ranks #276 out of 658 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Pulse Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Pulse Biosciences' 3-Year EPS without NRI Growth Rate compare to LMAT and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Pulse Biosciences ranks #276 out of 658 companies for 3-Year EPS without NRI Growth Rate. This puts Pulse Biosciences in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 8.05. Pulse Biosciences' value of 13.90% is 72.7% above this benchmark. While the company's 10-year median is 3.75 vs. the industry median of 8.05, Pulse Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.05, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulse Biosciences's current 3-Year EPS without NRI Growth Rate of 13.90% is 72.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Pulse Biosciences and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulse Biosciences's current 3-Year EPS without NRI Growth Rate is 13.90%, which is 271% above median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulse Biosciences stock overvalued right now?
Pulse Biosciences (PLSE) has a current 3-Year EPS without NRI Growth Rate of 13.90%. The current 3-Year EPS without NRI Growth Rate is 13.90%, which is 271% above median its 10-year median of 3.75 and 72.7% above the Medical Devices & Instruments industry median of 8.05. Pulse Biosciences' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Pulse Biosciences (PLSE), the current 3-Year EPS without NRI Growth Rate is 13.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
33GF Score
Get the complete analysis for PLSE
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLSE has been successfully added to your 
